The imbalance between MMP-9 and TIMP-1 in COPD patients favors a pro-proteolytic environment, collectively highlighting the importance of the MMP-9/TIMP-1 ratio as a potential biomarker for COPD diagnosis and severity assessment (43). This evidence concerns the gene MMP9 and chronic obstructive pulmonary disease.